Phase 2 clinical trial shows that ibudilast is linked to a 48% slowing in the progression of brain atrophy compared to placebo for patients with progressive MS.
clinical studies
-
Read more »
-
Read more »
Mobile has revolutionised everyday life and now big pharma is using smartphones and other mobile devices to improve research and development.
-
Read more »
What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?
-
Read more »
Promising Results from Multiple Studies
